SEC Form 4 · accession 0001179110-15-012442

ABIOMED INC · ABMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael R Minogue

Officer — President, CEO, Chairman · Director

Period of report

Aug 18, 2015

Accepted (ET)

Aug 20, 2015 · 7:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000815094

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock $.01 par value^F1	Aug 18, 2015	M	146,800	$5.86	A	386,518	D
Common Stock $.01 par value^F1,F7	Aug 18, 2015	S	38,126	$105.048	D	348,392	D
Common Stock $.01 par value^F1,F8	Aug 18, 2015	S	28,530	$105.9233	D	319,862	D
Common Stock $.01 par value^F1,F9	Aug 18, 2015	S	7,214	$106.7676	D	312,648	D
Common Stock $.01 par value^F1,F10	Aug 18, 2015	S	523	$107.4812	D	312,125	D
Common Stock $.01 par value^F1,F11	Aug 19, 2015	S	13,996	$102.9076	D	298,129	D
Common Stock $.01 par value^F1,F12	Aug 19, 2015	S	21,601	$103.7841	D	276,528	D
Common Stock $.01 par value^F1,F13	Aug 19, 2015	S	31,210	$104.7292	D	245,318	D
Common Stock $.01 par value^F1,F14	Aug 19, 2015	S	5,600	$105.5014	D	239,718	D
Common Stock $.01 par value^F15	holding	—	—		—	36,082	I	By Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Owned after	D/I
Stock Option (right to buy)^F3,F1,F2	$5.86	Aug 18, 2015	M	146,800	D	May 28, 2010	May 28, 2019	Common Stock	0	D
Stock Option (right to buy)^F6	$13.57	holding	—	—	—	Jun 1, 2007	Jun 1, 2016	Common Stock	82,000	D
Stock Option (right to buy)^F6,F2	$13.80	holding	—	—	—	May 23, 2009	May 23, 2018	Common Stock	28,333	D
Stock Option (right to buy)^F3,F4	$18.63	holding	—	—	—	Jun 15, 2009	Aug 13, 2018	Common Stock	76,875	D
Stock Option (right to buy)^F3,F2	$5.86	holding	—	—	—	May 28, 2010	May 28, 2019	Common Stock	56,700	D
Stock Option (right to buy)^F3,F2	$10.03	holding	—	—	—	Jun 3, 2011	Jun 3, 2020	Common Stock	105,000	D
Stock Option (Right to Buy)^F3,F2	$22.44	holding	—	—	—	May 22, 2013	May 22, 2022	Common Stock	50,000	D
Stock Option (Right to Buy)^F3,F2	$23.15	holding	—	—	—	May 14, 2014	May 14, 2024	Common stock	21,250	D
Stock Option (right to buy)^F3,F5	$21.55	holding	—	—	—	May 14, 2015	May 14, 2024	Common Stock	85,000	D
Stock Option (right to buy)^F3,F5	$66.25	holding	—	—	—	May 13, 2016	May 13, 2025	Common Stock	35,000	D

Explanation of responses

F1Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $107.4800 and $107.5150. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F11This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $102.3000 and $103.2750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F12This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $103.3100 and $104.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F13This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $104.3100 and $105.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F14This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.3100 and $105.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F15These securities are held by the Renee D. Minogue Revocable Trust, Renee D. Minogue, trustee DTD 12/29/2005.
F2These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
F3Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F4These options become exercisable based on the achievement of certain performance milestones.
F5These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F6Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $104.4100 and $105.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.4100 and $106.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $106.4100 and $107.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.